Chengxian Guo

University of Science and Technology of China — China

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

21h-index1.2kcitations112works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(23), Drug Transport and Resistance Mechanisms(9), Pharmacological Effects and Toxicity Studies(9), Head and Neck Cancer Studies(6), RNA modifications and cancer(6)

Publications112 total

Releasing the technological backlog: The role of digital transformation
Journal of Engineering and Technology Management·2025
Pharmacokinetics, safety, and tolerability of nacubactam (OP0595) after intravenous infusion: a randomized, double-blind, placebo-controlled phase I clinical trial in healthy Chinese male subjects
Clinical and Experimental Medicine·2025Open Access
SERS detection of antibiotics using dual plasmonic and charge transfer enhancement mechanism of Ag@MoS2 core-shell nanocomposites
Sensors and Actuators Reports·2025· 1 citedOpen Access
Safety Evaluation of Nitroimidazole Antibiotics Based on the <scp>FAERS</scp> Database
Clinical and Experimental Pharmacology and Physiology·2025· 1 citedOpen Access
Comprehensive disproportionality analysis of individual case safety reports associated with Janus kinase inhibitors in psoriasis and psoriatic arthritis using the FAERS database
Frontiers in Immunology·2025· 1 citedOpen Access
Population pharmacokinetic/pharmacodynamic model of LY06006 in Chinese healthy subjects and postmenopausal osteoporotic women
British Journal of Clinical Pharmacology·2025
Structural behaviours of WAAM 316L stainless steel bolted connections under tensile loading
Journal of Constructional Steel Research·2025
Safety Evaluation of Nitroimidazole Antibiotics Based on the FAERS Database
2025Open Access
Supply chain shareholding, climate policy uncertainty and total factor productivity of enterprises
Finance research letters·2025· 1 cited
Novel FNR-Dependent Oxygen-Responsive Promoters in <i>Escherichia coli</i>: Design, Characterization, and Metabolic Engineering Applications
ACS Synthetic Biology·2025· 1 cited
Robust Visual Trash Detection for Autonomous Highway Service Area Cleaning Under Severe Weather Conditions
2025
CSDE1 enhances genotoxic drug resistance in cancer by modulating RPA2 through CSDE1-eIF3a regulatory complex
Drug Resistance Updates·2025
Vitamin D deficiency enhances platelet activation and thrombosis by regulating VDR/Akt pathway based on platelet proteomics
European Journal of Pharmacology·2025· 3 cited
Association of antibiotics with Stevens–Johnson syndrome and toxic epidermal necrolysis: A real-world pharmacovigilance study
International Journal of Antimicrobial Agents·2025· 2 cited
Towards layer-wise quantization for heterogeneous federated clients
Computer Networks·2025· 4 cited
Experimental study on sacrificial agent performance to reduce the adsorption capacity of surfactants
2025
Identification and characterization of anaerobically activated promoters in Escherichia coli
Journal of Biotechnology·2025· 1 cited
eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m6A modification
Acta Pharmaceutica Sinica B·2025· 2 citedOpen Access
The impact of the COVID-19 pandemic on adverse events associated with ACEIs and ARBs: a real-world analysis using the FDA adverse event reporting system
Expert Opinion on Drug Safety·2025
Testing and numerical analysis of WAAM stainless steel T-stub connections
Journal of Constructional Steel Research·2025· 11 cited
page 1 of 6Next →

Frequent Co-authors

Guoping Yang(27), Qi Pei(17), Ji‐Ye Yin(16), Jingao Li(9), Hongyi Tan(9), Xiaoxue Xie(7), Jiajia Cui(7), Yun Kuang(7), Zhijun Huang(7), Jie Huang(7), Hong‐Hao Zhou(5), Lei‐Yun Wang(5), Qianying Ouyang(5), Lihua Huang(5), Chan Zou(5), Hong‐Hao Zhou(4), Yu‐Ling Huang(4), Lihua Huang(4), Chen Shao-jun(4), Biwen Hu(4)